A detailed history of Nebula Research & Development LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 9,492 shares of PTCT stock, worth $524,527. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,492
Holding current value
$524,527
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$34.99 - $52.07 $332,125 - $494,248
9,492 New
9,492 $428 Million
Q3 2023

Nov 14, 2023

BUY
$22.41 - $41.99 $489,837 - $917,817
21,858 New
21,858 $490 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.95B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.